about
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumabExperimental study on the photodynamic treatment of choroidal neovasculization with nanophthalocyanine photosensitizer.The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.Multifocal electroretinogram findings after intravitreal bevacizumab injection in choroidal neovascularization of age-related macular degeneration.Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Which treatment is best for which AMD patient?
@en
Which treatment is best for which AMD patient?
@nl
type
label
Which treatment is best for which AMD patient?
@en
Which treatment is best for which AMD patient?
@nl
prefLabel
Which treatment is best for which AMD patient?
@en
Which treatment is best for which AMD patient?
@nl
P2860
P356
P1476
Which treatment is best for which AMD patient?
@en
P2093
P2860
P304
P356
10.1136/BJO.2005.083337
P407
P50
P577
2006-02-01T00:00:00Z